Inventor · disambiguated record
Paula S. Hochman
Also filed as: HOCHMAN PAULA · HOCHMAN PAULA S
20 granted patents·4 pending applications·327 citations·filing 1995–2022
95Inventor score
Top patents by PatentIndex Score
24 records- 0193US6800735B2Interferon-beta fusion proteins and usesBIOGEN IDEC INC·Filed 2001·Granted Oct 5, 2004·65 cites·5 claims
- 0293US5925351ASoluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseaseBIOGEN INC·Filed 1995·Granted Jul 20, 1999·78 cites·16 claims
- 0388US6962978B2Polymer conjugates of interferon beta-1a and usesBIOGEN INC·Filed 2001·Granted Nov 8, 2005·29 cites·24 claims
- 0488US6403087B1Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological diseaseBIOGEN INC·Filed 1996·Granted Jun 11, 2002·52 cites·14 claims
- 0586US6669941B1Soluble lymphotoxin-β receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune diseaseBIOGEN INC·Filed 1999·Granted Dec 30, 2003·42 cites·14 claims
- 0683US7309492B2Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosusBIOGEN IDEC INC·Filed 2001·Granted Dec 18, 2007·13 cites·7 claims
- 0781US7744891B2Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseasesBIOGEN IDEC INC·Filed 2007·Granted Jun 29, 2010·3 cites·35 claims
- 0881US7427403B2Methods for inhibiting lymphotoxin β receptor signallingBIOGEN IDEC INC·Filed 2002·Granted Sep 23, 2008·9 cites·74 claims
- 0980US7951371B2Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signalingBIOGEN IDEC INC·Filed 2007·Granted May 31, 2011·2 cites·12 claims
- 1079US12385925B2Anti-VLA-4 related assaysBIOGEN MA INC·Filed 2022·Granted Aug 12, 2025·0 cites·40 claims
- 1173US7527946B2Interferon-beta-1a-immunoglobulin fusion proteins and usesBIOGEN IDEC INC·Filed 2004·Granted May 5, 2009·6 cites·10 claims
- 1273US7446173B2Polymer conjugates of interferon beta-1A and usesBIOGEN IDEC INC·Filed 2004·Granted Nov 4, 2008·5 cites·28 claims
- 1372US11280793B2Anti-VLA-4 related assaysBIOGEN MA INC·Filed 2019·Granted Mar 22, 2022·0 cites·21 claims
- 1472US7255854B1Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseasesBIOGEN INC·Filed 1999·Granted Aug 14, 2007·21 cites·35 claims
- 1569US9377458B2Anti-VLA-4 related assaysPLAVINA TATIANA·Filed 2010·Granted Jun 28, 2016·2 cites·53 claims
- 1661US2009286958A1Interferon-beta fusion proteins and usesBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 1760US10302654B2Anti-VLA-4 related assaysBIOGEN MA INC·Filed 2017·Granted May 28, 2019·0 cites·20 claims
- 1858US8455445B2Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disordersBROWNING JEFFREY L·Filed 2011·Granted Jun 4, 2013·0 cites·16 claims
- 1957US9726672B2Anti-VLA-4 related assaysBIOGEN MA INC·Filed 2016·Granted Aug 8, 2017·0 cites·46 claims
- 2055US2009104150A1Polymer conjugates of interferon Beta-1a and usesPEPINSKY BLAKE·Filed 2008·Application pending·0 cites
- 2154US8287874B2Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseasesBROWNING JEFFREY L·Filed 2010·Granted Oct 16, 2012·0 cites·29 claims
- 2254US2016250340A1POLYMER CONJUGATES OF INTERFERON BETA-1a AND USESBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2352US9314534B2Polymer conjugates of interferon beta-1A and usesPEPINSKY BLAKE·Filed 2012·Granted Apr 19, 2016·0 cites·6 claims
- 2442US2002132317A1Novel interferon-induced tetraspan protein and nucleic acids encoding sameFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →